Company Filing History:
Years Active: 2018-2025
Title: Waltraud Kaar: Innovator in Pharmaceutical Applications
Introduction
Waltraud Kaar is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of immunoglobulin compositions. With a total of four patents to her name, Kaar's work is recognized for its innovative approach to medical treatments.
Latest Patents
One of Kaar's latest patents is focused on a high concentration immunoglobulin composition for pharmaceutical applications. This invention relates to a liquid composition that includes polyclonal immunoglobulins, viscosity modulating amino acids such as arginine and histidine, and stabilizing amino acids like glycine and proline. The composition is designed to ensure that more than 90% of the polyclonal immunoglobulins are in the form of monomers or dimers, with less than 5% in the form of polymers. The immunoglobulin concentration in this composition exceeds 160 g/L, and the pH is maintained between 5.2 and 5.9. This invention also encompasses a method for formulating these highly concentrated polyclonal immunoglobulins for medical treatment.
Career Highlights
Waltraud Kaar is currently associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. Her work at Octapharma has allowed her to contribute to advancements in the pharmaceutical industry, particularly in the development of immunoglobulin therapies.
Collaborations
Kaar has collaborated with notable colleagues such as Karin Ahrer and Ulrich Roessl. These collaborations have further enhanced her research and development efforts in the field of pharmaceuticals.
Conclusion
Waltraud Kaar's innovative work in the formulation of immunoglobulin compositions has made a significant impact in the pharmaceutical industry. Her contributions continue to advance medical treatments and improve patient outcomes.